254 related articles for article (PubMed ID: 33766105)
1. Hematologists' barriers and enablers to screening and recruiting patients to a chimeric antigen receptor (CAR) T cell therapy trial: a theory-informed interview study.
Castillo G; Lalu M; Asad S; Foster M; Kekre N; Fergusson D; Hawrysh T; Atkins H; Thavorn K; Montroy J; Schwartz S; Holt R; Broady R; Presseau J;
Trials; 2021 Mar; 22(1):230. PubMed ID: 33766105
[TBL] [Abstract][Full Text] [Related]
2. Navigating choice in the face of uncertainty: using a theory informed qualitative approach to identifying potential patient barriers and enablers to participating in an early phase chimeric antigen receptor T (CAR-T) cell therapy trial.
Castillo G; Lalu MM; Asad S; Foster M; Kekre N; Fergusson DA; Hawrysh T; Atkins H; Thavorn K; Montroy J; Schwartz S; Holt RA; Broady R; Presseau J
BMJ Open; 2021 Mar; 11(3):e043929. PubMed ID: 33741670
[TBL] [Abstract][Full Text] [Related]
3. Barriers and facilitators to healthcare professional behaviour change in clinical trials using the Theoretical Domains Framework: a case study of a trial of individualized temperature-reduced haemodialysis.
Presseau J; Mutsaers B; Al-Jaishi AA; Squires J; McIntyre CW; Garg AX; Sood MM; Grimshaw JM;
Trials; 2017 May; 18(1):227. PubMed ID: 28532509
[TBL] [Abstract][Full Text] [Related]
4. What are potential barriers and enablers to patient and physician participation in Canadian cell therapy trials for stroke? A stakeholder interview study.
Lalu MM; Foster M; Presseau J; Dowlatshahi D; Castillo G; Cardenas A; Tam W; Zlepnig J; Timpson D; Dong YY; Juneau P; Fergusson DA
BMJ Open; 2020 Mar; 10(3):e034354. PubMed ID: 32198301
[TBL] [Abstract][Full Text] [Related]
5. Identifying barriers and enablers to opt-out hepatitis C virus screening in provincial prisons in Quebec, Canada: A multilevel, multi-theory informed qualitative study with correctional and healthcare professional stakeholders.
Ruiz AS; Fontaine G; Patey AM; Grimshaw JM; Presseau J; Cox J; Dussault C; Kronfli N
Int J Drug Policy; 2022 Nov; 109():103837. PubMed ID: 36030569
[TBL] [Abstract][Full Text] [Related]
6. A patient-focused, theory-guided approach to survey design identified barriers to and drivers of clinical trial participation.
Brehaut JC; Carroll K; Presseau J; Richards DP; Gordon J; Bénard A; Hudek N; Graham ID; Fergusson DA; Marlin S
J Clin Epidemiol; 2021 Apr; 132():106-115. PubMed ID: 33338563
[TBL] [Abstract][Full Text] [Related]
7. Results from a Theory-Guided Survey to Support Breast Cancer Trial Participation: Barriers, Enablers, and What to Do about them.
Brehaut JC; Carroll K; Gordon J; Presseau J; Richards DP; Fergusson DA; Graham ID; Marlin S
Curr Oncol; 2021 May; 28(3):2014-2028. PubMed ID: 34073279
[TBL] [Abstract][Full Text] [Related]
8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
9. Using the theoretical domains framework to identify barriers and enablers to pediatric asthma management in primary care settings.
Yamada J; Potestio ML; Cave AJ; Sharpe H; Johnson DW; Patey AM; Presseau J; Grimshaw JM
J Asthma; 2018 Nov; 55(11):1223-1236. PubMed ID: 29261346
[TBL] [Abstract][Full Text] [Related]
10. Partnering with patients to get better outcomes with chimeric antigen receptor T-cell therapy: towards engagement of patients in early phase trials.
Foster M; Fergusson DA; Hawrysh T; Presseau J; Kekre N; Schwartz S; Castillo G; Asad S; Fox G; Atkins H; Thavorn K; Montroy J; Holt RA; Monfaredi Z; Lalu MM
Res Involv Engagem; 2020; 6():61. PubMed ID: 33072399
[TBL] [Abstract][Full Text] [Related]
11. Understanding the Canadian adult CT head rule trial: use of the theoretical domains framework for process evaluation.
Curran JA; Brehaut J; Patey AM; Osmond M; Stiell I; Grimshaw JM
Implement Sci; 2013 Feb; 8():25. PubMed ID: 23433082
[TBL] [Abstract][Full Text] [Related]
12. Understanding potential barriers and enablers to a perioperative early phase cell therapy trial.
Foster M; Fergusson DA; Hunniford V; Cardenas A; Castillo G; Yaworsky J; Mazer CD; Devereaux PJ; McIsaac DI; Stewart DJ; Presseau J; Lalu MM
Cytotherapy; 2022 Jun; 24(6):629-638. PubMed ID: 35396169
[TBL] [Abstract][Full Text] [Related]
13. Primary care provider perceptions of enablers and barriers to following guideline-recommended laboratory tests to confirm chronic kidney disease: a qualitative descriptive study.
Nash DM; Garg AX; Brimble KS; Markle-Reid M
BMC Fam Pract; 2018 Dec; 19(1):192. PubMed ID: 30526501
[TBL] [Abstract][Full Text] [Related]
14. Understanding practice: factors that influence physician hand hygiene compliance.
Squires JE; Linklater S; Grimshaw JM; Graham ID; Sullivan K; Bruce N; Gartke K; Karovitch A; Roth V; Stockton K; Trickett J; Worthington J; Suh KN
Infect Control Hosp Epidemiol; 2014 Dec; 35(12):1511-20. PubMed ID: 25419774
[TBL] [Abstract][Full Text] [Related]
15. Addressing feasibility challenges to delivering intradialytic exercise interventions: a theory-informed qualitative study.
Castillo G; Presseau J; Wilson M; Cook C; Field B; Garg AX; McIntyre C; Molnar AO; Hogeterp B; Thornley M; Thompson S; MacRae JM; Bohm C
Nephrol Dial Transplant; 2022 Feb; 37(3):558-574. PubMed ID: 34415351
[TBL] [Abstract][Full Text] [Related]
16. Experiences and perspectives on chimeric antigen receptor (CAR) T-cell therapy among recipients, carers and referrers (RE-TELL): a qualitative study to inform CAR T-cell service design.
Fyfe R; Anstis O; Kapadia K; Jordan M; Sword DO; Weinkove R
BMJ Open; 2024 Jan; 14(1):e071112. PubMed ID: 38262637
[TBL] [Abstract][Full Text] [Related]
17. Identifying Barriers and Enablers to Attending Diabetic Retinopathy Screening in Immigrants to Canada From Ethnocultural Minority Groups: Protocol for a Qualitative Descriptive Study.
Dogba MJ; Brent MH; Bach C; Asad S; Grimshaw J; Ivers N; Légaré F; Witteman HO; Squires J; Wang X; Sutakovic O; Zettl M; Drescher O; van Allen Z; McCleary N; Tremblay MC; Linklater S; Presseau J
JMIR Res Protoc; 2020 Feb; 9(2):e15109. PubMed ID: 32049067
[TBL] [Abstract][Full Text] [Related]
18. Bladder-sparing Radiotherapy for Muscle-invasive Bladder Cancer: A Qualitative Study to Identify Barriers and Enablers.
Walker M; Doiron RC; French SD; Feldman-Stewart D; Siemens DR; Mackillop WJ; Booth CM
Clin Oncol (R Coll Radiol); 2017 Dec; 29(12):818-826. PubMed ID: 28951003
[TBL] [Abstract][Full Text] [Related]
19. Identifying the barriers and enablers for a triage, treatment, and transfer clinical intervention to manage acute stroke patients in the emergency department: a systematic review using the theoretical domains framework (TDF).
Craig LE; McInnes E; Taylor N; Grimley R; Cadilhac DA; Considine J; Middleton S
Implement Sci; 2016 Nov; 11(1):157. PubMed ID: 27894313
[TBL] [Abstract][Full Text] [Related]
20. Barriers to and enablers of attendance at diabetic retinopathy screening experienced by immigrants to Canada from multiple cultural and linguistic minority groups.
van Allen Z; Dogba MJ; Brent MH; Bach C; Grimshaw JM; Ivers NM; Wang X; McCleary N; Asad S; Chorghay Z; Hakim H; Sutakovic O; Drescher O; Légaré F; Witteman HO; Zettl M; Squires J; Tremblay MC; Randhawa A; Lopez G; Ben Guiza A; Presseau J
Diabet Med; 2021 Apr; 38(4):e14429. PubMed ID: 33068305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
